Benefit and harm of intravenous vasodilators across the clinical profile spectrum in acute cardiogenic pulmonary oedema patients

Background: The absence of high quality, large-scale data that indicates definitive mortality benefits does not allow for firm conclusions on the role of intravenous vasodilators in acute heart failure. We aimed to investigate the associations between intravenous vasodilators and clinical outcomes i...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European heart journal. Acute cardiovascular care 2020-08, Vol.9 (5), p.448-458, Article 2048872619891075
Hauptverfasser:	Shiraishi, Yasuyuki, Kohsaka, Shun, Katsuki, Toshiomi, Harada, Kazumasa, Miyazaki, Tetsuro, Miyamoto, Takamichi, Matsushita, Kenichi, Iida, Kiyoshi, Takei, Makoto, Yamamoto, Yoshiya, Shindo, Akito, Kitano, Daisuke, Nagatomo, Yuji, Jimba, Takahiro, Yamamoto, Takeshi, Nagao, Ken, Takayama, Morimasa
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Disease Aged Aged, 80 and over Blood Pressure - drug effects Cardiac & Cardiovascular Systems Cardiovascular System & Cardiology Female Follow-Up Studies Heart Failure - complications Heart Failure - drug therapy Heart Failure - physiopathology Humans Infusions, Intravenous Japan - epidemiology Life Sciences & Biomedicine Male Prognosis Pulmonary Edema - drug therapy Pulmonary Edema - etiology Pulmonary Edema - mortality Retrospective Studies Science & Technology Survival Rate - trends Vasodilation - drug effects Vasodilator Agents - administration & dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!